Mark J. Enyedy - Jun 30, 2023 Form 4 Insider Report for ImmunoGen, Inc. (IMGN)

Role
CHIEF EXECUTIVE OFFICER, Director
Signature
/s/ Renee Lentini, Attorney-in-Fact
Stock symbol
IMGN
Transactions as of
Jun 30, 2023
Transactions value $
$21,226
Form type
4
Date filed
7/5/2023, 05:57 PM
Previous filing
Feb 7, 2023
Next filing
Aug 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Award $21.2K +5.24K +1.2% $4.05* 441K Jun 30, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased due to participation by the reporting individual in the ImmunoGen Employee Stock Purchase Plan (the ESPP). It pertains to the ESPP purchase period from January 1, 2023 through June 30, 2023.
F2 In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the issuer's common stock on January 3, 2023.